The table below shows Teladoc Health, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$294.36M
$293.68M
$350.02M
$189.29M
$193.99M
-$53.51M
Capital expenditure
$8.89M
$10.79M
$11.46M
$16.48M
$8.53M
$4.02M
Investing cash flow
-$266.00M
-$124.05M
-$156.35M
-$167.74M
-$72.98M
-$590.98M
Dividends paid
-
-
-
-
-
TDOC operating cash flow (10-K history)
Teladoc Health, Inc. reported operating cash flow of $294.36M for fiscal year 2025. That is up 0.2% from $293.68M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$51.88M (FY 2016) to $294.36M. Figures come from the company's audited annual reports as filed with the SEC.
